Strategies for Optimizing Liver Health in Diabetic Patients
Listen now
Description
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Scott D. Isaacs, MD FACP, FACE Since type 2 diabetes is the number one risk factor for the progression to advanced liver fibrosis, monitoring diabetic patients is absolutely critical, especially considering the fact that the symptoms of disease progression can be nonexistent or very vague. Here with Dr. Mary Katherine Cheeley to break down the latest guidelines and strategies for monitoring liver health in patients with diabetes is endocrinologist Dr. Scott D. Isaacs.
More Episodes
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: David P. Hudesman, MD There’s been an increase in the elderly irritable bowel disease (IBD) population, and it’s estimated that a third of our overall IBD population will soon be over the age of 60. When managing and diagnosing these...
Published 05/16/24
Published 05/16/24
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Francis Farraye, MD Patients with inflammatory bowel disease (IBD) have an increased risk of developing infections, and some may be preventable with a vaccine. Approximately 70 percent of patients with ulcerative colitis or Crohn’s...
Published 05/01/24